Osaic Holdings’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.07M Sell
1,348,127
-97
-0% -$424 0.01% 1223
2025
Q4
$6.48M Buy
1,348,224
+9,721
+0.7% +$43.7K 0.01% 1201
2025
Q3
$5.97M Sell
1,338,503
-13
-0% -$48 0.01% 1336
2025
Q2
$4.14M Sell
1,338,516
-6,390
-0.5% -$21.2K 0.01% 1371
2025
Q1
$4.69M Sell
1,344,906
-2,418
-0.2% -$8.06K 0.01% 1074
2024
Q4
$4.41M Sell
1,347,324
-25,030
-2% -$92.1K 0.01% 1108
2024
Q3
$5.28M Buy
1,372,354
+2,515
+0.2% +$9.65K 0.01% 1005
2024
Q2
$4.23M Buy
1,369,839
+2,300
+0.2% +$6.9K 0.01% 1106
2024
Q1
$3.53M Hold
1,367,539
0.01% 1288
2023
Q4
$3.42M Sell
1,367,539
-500
-0% -$979 0.01% 1462
2023
Q3
$2.78M Buy
1,368,039
+1,000
+0.1% +$2.1K ﹤0.01% 1715
2023
Q2
$3.14M Sell
1,367,039
-9,484
-0.7% -$24.7K 0.01% 1505
2023
Q1
$4.17M Hold
1,376,523
0.01% 1285
2022
Q4
$3.21M Buy
1,376,523
+12,000
+0.9% +$28.7K 0.01% 1399
2022
Q3
$2.61M Hold
1,364,523
0.01% 1433
2022
Q2
$3.7M Sell
1,364,523
-1
-0% -$3 0.01% 1240
2022
Q1
$4.07M Sell
1,364,524
-370
-0% -$1.13K 0.01% 1355
2021
Q4
$5.31M Buy
1,364,894
+330
+0% +$1.28K 0.01% 1063
2021
Q3
$5.85M Sell
1,364,564
-5,125
-0.4% -$17.1K 0.01% 963
2021
Q2
$4.15M Sell
1,369,689
-400
-0% -$1.24K 0.01% 1152
2021
Q1
$4.56M Sell
1,370,089
-1,000
-0.1% -$3.86K 0.01% 1016
2020
Q4
$4.87M Buy
1,371,089
+10,800
+0.8% +$37.8K 0.01% 895
2020
Q3
$4.26M Sell
1,360,289
-414,646
-23% -$1.26M 0.01% 854
2020
Q2
$3.23M Buy
1,774,935
+20
+0% +$33 0.01% 944
2020
Q1
$1.79M Buy
+1,774,915
New +$4.8M 0.01% 1128

Other funds holding ABUS